日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights

在复发性子宫内膜癌和卵巢癌患者中应用Copanlisib和Niraparib联合治疗(COPANIRA):疗效、毒性和转化研究进展

Brodsky, Allison L; Asare, Amma; Fellman, Bryan; Anderson, Kristin; Yao, Jun; Lee, Sanghoon; Tran, Hai; Xu, Xun; Liu, Jinsong; Celestino, Joseph; Hajek, Richard A; Morgan, Margaret B; Mohammad, Mohammad; Soliman, Pamela; Shafer, Aaron; Sood, Anil K; Bodurka, Diane; Fleming, Nicole D; Onstad Grinsfelder, Michaela; Milojevic, Ljiljana; Jazaeri, Amir A; Mills, Gordon B; Coleman, Robert L; Westin, Shannon N

Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapy

作者更正:PPP2R1A突变预示着癌症免疫治疗后生存率的提高

Dai, Yibo; Knisely, Anne; Yano, Mitsutake; Dang, Minghao; Hinchcliff, Emily M; Lee, Sanghoon; Welp, Annalyn; Chelvanambi, Manoj; Lastrapes, Matthew; Liu, Heng; Yuan, Zhe; Wang, Chen; Nie, Hao; Jean, Stephanie; Montaner, Luis J; Hou, Jiakai; Patel, Ami; Patel, Shrina; Fellman, Bryan; Yuan, Ying; Sun, Baohua; Pandurengan, Renganayaki Krishna; Cuentas, Edwin Roger Parra; Celestino, Joseph; Liu, Yan; Liu, Jinsong; Hillman, R Tyler; Westin, Shannon N; Sood, Anil K; Soliman, Pamela T; Shafer, Aaron; Meyer, Larissa A; Gershenson, David M; Vining, David; Ganeshan, Dhakshinamoorthy; Lu, Karen; Wargo, Jennifer A; Peng, Weiyi; Zhang, Rugang; Wang, Linghua; Jazaeri, Amir A

Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities

一线治疗后卵巢癌患者的手术和血液学微小残留病灶:临床结果和转化机会

Knisely, Anne; Dai, Yibo; Barlow, Graham L; Lee, Sanghoon; Lawson, Barrett; Clark, Helen; Fellman, Bryan; Yuan, Ying; Lu, Wei; Lubo Julio, Idania Carolina; Lazcano, Rossana N; Chelvanambi, Manoj; Melendez, Brenda; Singh, Bharat; Singh, Bhavana; Wani, Khalida; Chen, Jianfeng; Yeh, Chih-Chen; Gao, Jianjun; Barnes, Sean; Shi, Ou; Khan, Khaja B; Serrano, Alejandra G; Gomez-Bolanos, Lorena I; Scalise, Carly Bess; Cheung, Samantha K; Dutta, Punashi; Velichko, Sharlene; ElNaggar, Adam C; Liu, Minetta C; Wilke, Roni N; How, Jeffrey; Ramondetta, Lois M; Boruta, David M; Richardson, Gwyn; Shafer, Aaron; Westin, Shannon N; Sims, Travis; Sood, Anil K; Ramirez, Pedro T; Lazar, Alexander J; Soliman, Pamela T; Lu, Karen; Haymaker, Cara L; Solis Soto, Luisa M; Wargo, Jennifer A; Grisham, Rachel; Wucherpfennig, Kai W; Wang, Linghua; Jazaeri, Amir A

Trends in Endometrial Cancer Incidence Among Premenopausal and Postmenopausal Women in the United States Between 2001 and 2021

2001年至2021年美国绝经前和绝经后妇女子宫内膜癌发病率趋势

Guo, Fangjian; Adekanmbi, Victor; Hsu, Christine D; Hoang, Thao N; Soliman, Pamela T; Baillargeon, Jacques G; Berenson, Abbey B

A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer

一项针对晚期或复发性子宫内膜癌患者的替西罗莫司联合二甲双胍的I期研究

Ahmed, Jibran; Stephen, Bettzy; Khawaja, Muhammad R; Yang, Yali; Salih, Israa; Barrientos-Toro, Elizve; Raso, Maria Gabriela; Karp, Daniel D; Piha-Paul, Sarina A; Sood, Anil K; Ng, Chaan S; Johnson, Amber; Soliman, Pamela T; Meric-Bernstam, Funda; Lu, Karen H; Naing, Aung

Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression

贝伐单抗在疾病进展后的治疗:卵巢癌、输卵管癌和腹膜癌患者在疾病进展后再次接受贝伐单抗治疗的影响

Asare, Amma; Previs, Rebecca Ann; Spinosa, Daniel; Fellman, Bryan; Scott, Amelia L; Mulder, Isabelle; Mahmoud, May; Enbaya, Ahmed; Siedel, Jean Hansen; Cobb, Lauren; Soliman, Pamela T; Sood, Anil K; Coleman, Robert L; Secord, Angeles Alvarez; Westin, Shannon N

Translating biological insights into improved management of endometrial cancer

将生物学见解转化为子宫内膜癌治疗的改进

How, Jeffrey A; Jazaeri, Amir A; Westin, Shannon N; Lawson, Barrett C; Klopp, Ann H; Soliman, Pamela T; Lu, Karen H

Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers

妇科肿瘤中RAS突变的临床和基因组图谱

Son, Ji; Zhang, Yingao; Lin, Heather; Mirallas, Oriol; Alvarez Ballesteros, Pablo; Nardo, Mirella; Clark, Natalie; Hillman, R Tyler; Campbell, Erick; Holla, Vijaykumar; Johnson, Amber M; Biter, Amadeo B; Yuan, Ying; Cobb, Lauren P; Gershenson, David M; Jazaeri, Amir A; Lu, Karen H; Soliman, Pamela T; Westin, Shannon N; Euscher, Elizabeth D; Lawson, Barrett C; Yang, Richard K; Meric-Bernstam, Funda; Hong, David S

Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas

DNA修复基因RNase H2的缺失可识别DDR缺陷型平滑肌肉瘤的一个独特亚群

Nakazawa, Michael S; Silverman, Ian M; Rimkunas, Victoria; Veloso, Artur; Glodzik, Dominik; Johnson, Adrienne; Ohsumi, Toshiro K; Patel, Shreyaskumar R; Conley, Anthony P; Roland, Christina L; Soliman, Pamela T; Beird, Hannah C; Wu, Chia-Chin; Ingram, Davis R; Lazcano, Rossana; Song, Dawon; Wani, Khalida M; Lazar, Alexander J; Yap, Timothy A; Wang, Wei-Lien; Livingston, J Andrew

Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer

一项随机 II 期试验比较了 tremelimumab 和 durvalumab 联合用药与序贯用药治疗复发性铂耐药卵巢癌的疗效。

Hinchcliff, Emily M; Knisely, Anne; Adjei, Naomi; Fellman, Bryan; Yuan, Ying; Patel, Ami; Xu, Cai; Westin, Shannon N; Sood, Anil K; Soliman, Pamela T; Shafer, Aaron; Fleming, Nicole D; Gershenson, David M; Vikram, Raghunandan; Bathala, Tharakeswara; Vining, David; Ganeshan, Dhakshina M; Lu, Karen H; Sun, Charlotte C; Meyer, Larissa A; Jazaeri, Amir A